Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C12H14O3 |
| Molecular Weight | 206.2378 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1CC2=CC(CC(O)=O)=CC=C2O1
InChI
InChIKey=MYQXHLQMZLTSDB-UHFFFAOYSA-N
InChI=1S/C12H14O3/c1-2-10-7-9-5-8(6-12(13)14)3-4-11(9)15-10/h3-5,10H,2,6-7H2,1H3,(H,13,14)
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0019371 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6475669 |
|||
Target ID: GO:0070527 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7359316 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of SAS 650 (Furofenac) on malondialydehyde production by platelets. | 1984-06 |
|
| Mass spectrometry of the metabolites of 2-ethyl-2,3-dihydro-5-benzofuranylacetic acid. | 1980-06 |
|
| Metabolites and analogs of 2-ethyl-2,3-dihydro-5-benzofuranacetic acid (furofenac): chemical and pharmacological properties. | 1980-02 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
200959-06-4
Created by
admin on Mon Mar 31 21:38:42 GMT 2025 , Edited by admin on Mon Mar 31 21:38:42 GMT 2025
|
PRIMARY | |||
|
9EP849A4GR
Created by
admin on Mon Mar 31 21:38:42 GMT 2025 , Edited by admin on Mon Mar 31 21:38:42 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD